Applications published 27 July 2011
Selected patent applications from the weekly European Patents Bulletin
- A method of inhibiting hepatitis C virus by combination of a 5,6-dihydro-1H-pyridin-2-one and one or more additional antiviral compounds
Anadys Pharmaceuticals 2346329*
- Antimicrobial compsns and uses
Universitet I Oslo 2346330*
- Pyrido (4,3-B) indols containing rigid moieties
Medivation Technologies 2346332*
- Oxazolobenzimidazole derivatives
Merck Sharp & Dohme 2346334*
- Compsns comprising cinnamon oil (and/or its component cinnamaldehyde) and diallyl disulphide, their formulations, and methods of use
Valent Biosciences 2346338*
- Chewable gelled emulsions
ProBio 2346490*
- Novel pharmaceutical uses for nanoparticles
Centre National de le Recherche Scientifique; University Claude Bernard Lyon; Institut National de la Sante et de la Recherche Medicale 2346491*
- A process for nanoemulsification of curcumin and derivatives of curcumin
Laila Pharmaceuticals 2346492*
- Multiparticulate tablet and method for the production thereof
ADD Technologies 2346493*
- Extended release dosage form of ropinirole
Wockhardt 2346494*
- Pharmaceutical formulation 514
AstraZeneca 2346495*
- Method for coating objects
Bayer Healthcare 2346496*
- Compound for the local deletion of tumours
Frid, Noureddine 2346497*
- Methods of reducing small, dense LDL particles
Metabolex 2346498*
- Smoothened antagonism for the treatment of hedgehog pathway-related disorders
Novartis 2346499*
- Methods and compsns for improving cognitive function
The Johns Hopkins University 2346500*
- Use of cationic surfactants for the inactivation of toxins
Vedeqsa 2346501*
- Derivatives of hypoestoxides for the treatment of malaria
Immune Modulation 2346502*
- KV1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia
Hospital Clinic i Provincial de Barcelona; Universidad de Valladolid 2346503*
- Combinations comprising bicyclic S1P lyase inhibitors
Lexicon Pharmaceuticals 2346504*
- Indole and benzomorpholine derivatives as modulators of metabolic glutamate receptors
Ortho-McNeil-Janssen Pharmaceuticals 2346505*
- Administration scheme of polar opioid metabolites for post-operative pain management
Paion UK 2346506*
- Use of quinazoline derivatives for the treatment of viral diseases
Boehringer Ingelheim International 2346507*
- Heterocyclic kinase inhibitors
Intellikine 2346508*
- Inhalation of levofloxacin for reducing lung inflammation
Mpex Pharmaceuticals 2346509*
- Use of tripterpenic and anthraquinone glycosides as substances exerting hydragogue activity on mucosa of the upper respiratory tract, for the treatment of upper respiratory tract diseases
Soriana, Sandro 2346510*
- Method for treating pulmonary arterial hypertension
Sam Amer & Co 2346511*
- Compsn for prevention and treatment of allergenic and/or inflammatory diseases
Protectimmun; Forschungszentrum Borstel; Ruhr-Universität Bochum 2346512*
- Compsns comprising polymers having amino sugar units and methods of making and using same
Bausch & Lomb 2346513*
- Medium derived from stem cells as a pharmaceutical compsn
Omnicyte 2346514*
- Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents
Invivo Therapeutics 2346515*
- Antimicrobial compsn from copepods
Nofima Ingredients 2346516*
- Plant extract hydroxylates and antibacterial product containing the same
Bionorica 2346517*
- Process for extracting cardiac glycosides and compsns
Nerium Biotechnology 2346518*
- Methods and formulations for treating chronic liver disease
Zabrecky, George 2346519*
- Curcuminoids and its metabolites for the application in ocular diseases
Laila Pharmaceuticals 2346520*
- Peptides and methods of use
The Regents of the University of California 2346521*
- Methods of modulating protein homeostasis, metabolic syndrome, heavy metal intoxication and NRF2 transcription factors
Bach Pharma 2346522*
- A multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia
The United States of America, as represented by the Secretary, Department of Health and Human Services 2346523*
- New therapy and medicament using integrin ligands for treating cancer
Merck Patent 2346524*
- Methods of modulating the negative chemotaxis of immune cells
Celtaxsys 2346525*
- Compsns and methods of using ligand dimers
Massachusetts Institute of Technology 2346526*
- Medicinal products for the treatment of blood coagulation disorders containing thrombin-free factor XIA concentrate
Bio-Products & Bio-Engineering Aktiengesellschaft 2346527*
- Nicotine immunonanotherapeutics
Massachusetts Institute of Technology; President and Fellows of Harvard College; The Brigham & Women’s Hospital 2346528*
- Human M2E peptide immunogens
Theraclone Sciences 2346529*
- Immunostimulant compsns comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria
Bioibercia 2346530*
- Tumour vaccine
University of Miami 2346531*
- Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same
Bracco Suisse 2346532*